Context Therapeutics Inc. CNTX Q1 2025 earnings
Reported May 7, 2025 · Before market open
EPS-$0.05In line
EPS estimate-$0.05
Next report
Aug 5, 2026 (In 1 week)EPS estimate-$0.10
Versus estimates
Ask the moment Context Therapeutics Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Context Therapeutics Inc. report Q1 2025 earnings?
- Context Therapeutics Inc. (CNTX) reported Q1 2025 earnings on May 7, 2025 before market open.
- What were Context Therapeutics Inc.'s Q1 2025 revenue and EPS?
- Context Therapeutics Inc. reported eps of $-0.05 for Q1 2025.
- Did Context Therapeutics Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.05 by $0.00.
- How did Context Therapeutics Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 78.3% from $-0.23.
- Where can I find Context Therapeutics Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001842952-25-000048) directly on SEC EDGAR. The filing index links above go to sec.gov.